Robert D Annett - JoVE Visualize

Showing results (51-60 of 54) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 54 results.

JAMA Network Open|April 26, 2023

Assessment of Psychosocial and Neonatal Risk Factors for Trajectories of Behavioral Dysregulation Among Young Children From 18 to 72 Months of AgeJulie A Hofheimer, Monica McGrath, Rashelle Musci, et al.

Pediatrics|January 2, 2021

Site-Level Variation in the Characteristics and Care of Infants With Neonatal Opioid WithdrawalLeslie W Young, Zhuopei Hu, Robert D Annett, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2022

Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and LymphomaDavid T Teachey, Meenakshi Devidas, Brent L Wood, et al.

Blood|March 8, 2024

MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231Robert J Hayashi, Michelle L Hermiston, Brent L Wood, et al.

Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 54 results.

JAMA Network Open|April 26, 2023

Assessment of Psychosocial and Neonatal Risk Factors for Trajectories of Behavioral Dysregulation Among Young Children From 18 to 72 Months of AgeJulie A Hofheimer, Monica McGrath, Rashelle Musci, et al.

Pediatrics|January 2, 2021

Site-Level Variation in the Characteristics and Care of Infants With Neonatal Opioid WithdrawalLeslie W Young, Zhuopei Hu, Robert D Annett, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 2022

Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and LymphomaDavid T Teachey, Meenakshi Devidas, Brent L Wood, et al.

Blood|March 8, 2024

MRD at the end of induction and EFS in T-cell lymphoblastic lymphoma: Children's Oncology Group trial AALL1231Robert J Hayashi, Michelle L Hermiston, Brent L Wood, et al.

Pageof 6